These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 2457020)

  • 1. High and low affinity binding of heparin-binding growth factor to a 130-kDa receptor correlates with stimulation and inhibition of growth of a differentiated human hepatoma cell.
    Kan M; DiSorbo D; Hou JZ; Hoshi H; Mansson PE; McKeehan WL
    J Biol Chem; 1988 Aug; 263(23):11306-13. PubMed ID: 2457020
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fibronectin, not laminin, mediates heparin-dependent heparin-binding growth factor type I binding to substrata and stimulation of endothelial cell growth.
    Kan M; Shi EG
    In Vitro Cell Dev Biol; 1990 Dec; 26(12):1151-6. PubMed ID: 1706698
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bifunctional effects of transforming growth factor-beta (TGF-beta) on endothelial cell growth correlate with phenotypes of TGF-beta binding sites.
    Myoken Y; Kan M; Sato GH; McKeehan WL; Sato JD
    Exp Cell Res; 1990 Dec; 191(2):299-304. PubMed ID: 1701723
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heparin-binding growth factor 1 stimulates tyrosine phosphorylation in NIH 3T3 cells.
    Friesel R; Burgess WH; Maciag T
    Mol Cell Biol; 1989 May; 9(5):1857-65. PubMed ID: 2473389
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Purification form human hepatoma cells of a 130-kDa membrane glycoprotein with properties of the heparin-binding growth factor receptor.
    DiSorbo D; Shi EG; McKeehan WL
    Biochem Biophys Res Commun; 1988 Dec; 157(3):1007-14. PubMed ID: 2462864
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential inhibitory effects of TGF-beta on EGF-, PDGF-, and HBGF-1-stimulated MG63 human osteosarcoma cell growth: possible involvement of growth factor interactions at the receptor and postreceptor levels.
    Mioh H; Chen JK
    J Cell Physiol; 1989 Jun; 139(3):509-16. PubMed ID: 2472412
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Receptor phenotype underlies differential response of hepatocytes and nonparenchymal cells to heparin-binding fibroblast growth factor type 1 (aFGF) and type 2 (bFGF).
    Kan M; Yan GC; Xu J; Nakahara M; Hou J
    In Vitro Cell Dev Biol; 1992; 28A(7-8):515-20. PubMed ID: 1381709
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Possible dissociation of the heparin-binding and mitogenic activities of heparin-binding (acidic fibroblast) growth factor-1 from its receptor-binding activities by site-directed mutagenesis of a single lysine residue.
    Burgess WH; Shaheen AM; Ravera M; Jaye M; Donohue PJ; Winkles JA
    J Cell Biol; 1990 Nov; 111(5 Pt 1):2129-38. PubMed ID: 1699952
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human vascular smooth muscle cells both express and respond to heparin-binding growth factor I (endothelial cell growth factor).
    Winkles JA; Friesel R; Burgess WH; Howk R; Mehlman T; Weinstein R; Maciag T
    Proc Natl Acad Sci U S A; 1987 Oct; 84(20):7124-8. PubMed ID: 2444975
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heparin-binding growth factor type 1 (acidic fibroblast growth factor): a potential biphasic autocrine and paracrine regulator of hepatocyte regeneration.
    Kan M; Huang JS; Mansson PE; Yasumitsu H; Carr B; McKeehan WL
    Proc Natl Acad Sci U S A; 1989 Oct; 86(19):7432-6. PubMed ID: 2477840
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recovery of mitogenic activity of a growth factor mutant with a nuclear translocation sequence.
    Imamura T; Engleka K; Zhan X; Tokita Y; Forough R; Roeder D; Jackson A; Maier JA; Hla T; Maciag T
    Science; 1990 Sep; 249(4976):1567-70. PubMed ID: 1699274
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ability of different chemically modified heparins to potentiate the biological activity of heparin-binding growth factor 1: lack of correlation with growth factor binding.
    Belford DA; Hendry IA; Parish CR
    Biochemistry; 1992 Jul; 31(28):6498-503. PubMed ID: 1378755
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Opposite effects of monokines (interleukin-1 and tumor necrosis factor) on proliferation and heparin-binding (fibroblast) growth factor binding to human aortic endothelial and smooth muscle cells.
    Sawada H; Kan M; McKeehan WL
    In Vitro Cell Dev Biol; 1990 Feb; 26(2):213-6. PubMed ID: 2312505
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 16-kilodalton heparin binding (fibroblast) growth factor type one appears in a stable 40-kilodalton complex after receptor-dependent internalization.
    Shi E; Kan M; Xu JM; McKeehan WL
    J Biol Chem; 1991 Mar; 266(9):5774-9. PubMed ID: 2005115
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heparin-binding growth factor gene expression and receptor characteristics in normal rat prostate and two transplantable rat prostate tumors.
    Mansson PE; Adams P; Kan M; McKeehan WL
    Cancer Res; 1989 May; 49(9):2485-94. PubMed ID: 2468410
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heparin-binding growth factor-1 stimulation of human endothelial cells induces platelet-derived growth factor A-chain gene expression.
    Gay CG; Winkles JA
    J Biol Chem; 1990 Feb; 265(6):3284-92. PubMed ID: 1689299
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Monoclonal antibodies against heparin-binding growth factor-1: neutralization of biological activity and recognition of specific amino acid sequence.
    Myoken Y; Kan M; Chen J; McKeehan WL; Sato GH; Sato JD
    Biochem Biophys Res Commun; 1993 Dec; 197(3):1450-7. PubMed ID: 7506543
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phorbol ester reduces number of heparin-binding growth-factor receptors in human adult endothelial cells.
    Hoshi H; Kan M; Mioh H; Chen JK; McKeehan WL
    FASEB J; 1988 Sep; 2(12):2797-800. PubMed ID: 2457532
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Internalization and degradation of heparin binding growth factor-I by endothelial cells.
    Friesel R; Maciag T
    Biochem Biophys Res Commun; 1988 Mar; 151(3):957-64. PubMed ID: 2451523
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potentiation of the activity of mouse liver-derived HBGF-1-like growth factor by heparin and dithiothreitol: evidence for the involvement of a plasma factor.
    Nagasaki T; Lieberman MA
    Biochim Biophys Acta; 1991 Sep; 1094(3):330-8. PubMed ID: 1716989
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.